Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession

Abstract

Covid-19, a worldwide disease, affects millions of people. As of now, there is no effective technique to avoid infection. This outbreak emphasizes pandemic preparedness. Contrary to popular belief, the Covid-19 vaccination is delivered via transdermal microneedling rather than parenteral administration. Dissolving microneedles are best suited to eliciting the necessary immunity and antibody against Covid-19. It also allows for delayed and sustained antigen delivery, making it an effective pharmacological approach for immunizing. Why Transdermal microneedle vaccine administration allows for individualized distribution and reduced vaccine waste, while parenteral vaccine delivery is intrusive, requires cold chain storage, and does not allow for customized delivery. The challenges of clinical translation and sterilization are simply overcome by greater research. Vaccines are also avoided due to needle phobia, which is eliminated with painless transdermal microneedle delivery. Transdermal microneedle delivery may help us reach our aim of vaccinating as many individuals as possible.